Showing results (221-230 of 277) with videos related to
Sort By:
Pageof 28
The Journal of Biological Chemistry|June 5, 2007
Activation of inhibitors by sortase triggers irreversible modification of the active siteAnthony W Maresso, Ruiying Wu, Justin W Kern, et al.Soft Matter|March 16, 2018
Switching "on" and "off" the adhesion in stimuli-responsive elastomersS Kaiser, S V Radl, J Manhart, et al.Leukemia|August 21, 2013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant diseaseA Kohlmann, N Nadarajah, T Alpermann, et al.Leukemia|July 17, 1998
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparisonW Kern, C Aul, G Maschmeyer, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 5, 2010
Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patientsM Schütt, W Kern, A Zimmermann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancerW Kern, B Beckert, N Lang, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 1, 1997
Pharmacokinetics of aztreonam in critically ill surgical patientsE E Cornwell, H Belzberg, T V Berne, et al.Annals of Hematology|April 1, 1997
Frequency and causes of refractoriness in multiply transfused patientsT J Legler, I Fischer, J Dittmann, et al.Alzheimer Disease and Associated Disorders|November 13, 2014
Evaluation of a Brief Survey Instrument for Assessing Subtle Differences in Cognitive Function Among Older AdultsAshwin A Kotwal, Philip Schumm, David W Kern, et al.Annals of Hematology|October 31, 1998
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative GroupW Kern, C Aul, G Maschmeyer, et al.Pageof 28